An examination of multiple explanations for secondary hyperparathyroidism

被引:1
|
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [3 ,4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Methodist LeBonheur Healthcare, Memphis, TN USA
[4] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
关键词
secondary hyperparathyroidism; chronic kidney disease; phosphate; vitamin D; fibroblast growth factor 23; PARATHYROID-HORMONE; VITAMIN-D; KIDNEY; PHOSPHATE; PHOSPHORUS; CALCIUM; PTH; FGF23; 1,25-DIHYDROXYVITAMIN-D; PATHOGENESIS;
D O I
10.5414/CN110043
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Seven theories address the evolution of secondary hyperparathyroidism (SHPT) as chronic kidney disease (CKD) progresses. The tradeoff-in-the-nephron hypothesis states that the plasma parathyroid hormone ([PTH]) concentration rises because an increased phosphate concentration in the cortical distal nephron ([P](CDN)) reduces the ionized calcium concentration in that segment. In the present study, we compared this hypothesis to its predecessors. Materials and methods: We studied 30 patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73m(2) (mean 29.5). To examine historic theories, we performed regressions of [PTH] on plasma concentrations of ionized calcium, phosphorus, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and fibroblast growth factor 23, and on calcium excreted per volume of filtrate (E-Ca/C-cr). To assess the tradeoff-in-the-nephron hypothesis, we examined regressions of [PTH] on 100/eGFR and phosphorus excreted per volume of filtrate (E-P/C-cr). Results: Regressions pertinent to historic theories yielded significant direct relationships between [PTH] and both E-Ca/C-cr and [FGF23], but neither association supported the theory to which it pertained. [PTH] varied directly with 100/eGFR and with E-P/C-cr, a surrogate for [P](CDN). E-P/C-cr correlated strongly with 100/eGFR. Conclusions: The only theory of SHPT that our data support is the tradeoff-in-the-nephron hypothesis. Other theories are not supported.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [31] Impact of Vitamin D Dose on Biochemical Parameters in Patients with Secondary Hyperparathyroidism Receiving Cinacalcet
    Wilkie, Martin
    Pontoriero, Giuseppe
    Macario, Fernando
    Yaqoob, Magdi
    Bouman, Koen
    Braun, Johann
    von Albertini, Beat
    Brink, Hans
    Maduell, Francisco
    Graf, Helmut
    Frazao, Joao M.
    Bos, Willem Jan
    Torregrosa, Vicente
    Saha, Heikki
    Reichel, Helmut
    Zani, Valter J.
    Carter, Dave
    Messa, Piergiorgio
    NEPHRON CLINICAL PRACTICE, 2009, 112 (01): : C41 - C50
  • [32] Effect of Gastric Bypass on Vitamin D and Secondary Hyperparathyroidism
    Signori, Carina
    Zalesin, Kerstyn C.
    Franklin, Barry
    Miller, Wendy L.
    McCullough, Peter A.
    OBESITY SURGERY, 2010, 20 (07) : 949 - 952
  • [33] Parathyroidectomy reduces the costs of medication in patients with secondary hyperparathyroidism
    Pereira, Gabriel Mattucci Domingues
    Liao, Matheus
    Arap, Sergio Samir
    Magnabosco, Felipe Ferraz
    Brescia, Marilia D'Elboux Guimaraes
    Moyses, Rosa Maria Affonso
    Custodio, Melani Ribeiro
    Jorgetti, Vanda
    Kowalski, Luiz Paulo
    Montenegro, Fabio Luiz de Menezes
    CLINICS, 2024, 79
  • [34] Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation
    Lukas, Steffen
    Giusi, Moffa
    Philip, Mueller C.
    Daniel, Oertli
    SWISS MEDICAL WEEKLY, 2019, 149
  • [35] Secondary hyperparathyroidism among Nigerians with chronic kidney disease
    Gimba, Zumnan M.
    Abene, Esala E.
    Agbaji, Oche O.
    Agaba, Emmanuel, I
    AFRICAN HEALTH SCIENCES, 2018, 18 (02) : 446 - 457
  • [36] Economic burden of secondary hyperparathyroidism in Germany: a matched comparison
    Reichel, Helmut
    Seibert, Eric
    Tillmann, Frank-Peter
    Barck, Isabella
    Grava, Astride
    Schneider, Kim Maren
    Meise, Dominic
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1291 - 1300
  • [37] Emerging drugs for secondary hyperparathyroidism
    Cozzolino, Mario
    Tomlinson, James
    Walsh, Liron
    Bellasi, Antonio
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 197 - 208
  • [38] Secondary Hyperparathyroidism in Heart Failure
    Morsy, Mohamed S.
    Dishmon, Dwight A.
    Garg, Nadish
    Weber, Karl T.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (04) : 335 - 338
  • [39] Treatments for secondary hyperparathyroidism in hemodialysis
    Cozzolino, Mario
    Messa, Piergiorgio
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 807 - 809
  • [40] Advances in pharmacotherapy for secondary hyperparathyroidism
    Rodriguez, Mariano
    Rodriguez-Ortiz, Maria E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1703 - 1716